BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24417436)

  • 1. The chiral potential of phenanthriplatin and its influence on guanine binding.
    Johnstone TC; Lippard SJ
    J Am Chem Soc; 2014 Feb; 136(5):2126-34. PubMed ID: 24417436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
    Park GY; Wilson JJ; Song Y; Lippard SJ
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11987-92. PubMed ID: 22773807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the cytotoxic activity of phenanthriplatin dependent on the specific size of the phenanthridine ligand π system?
    Scoditti S; Dabbish E; Sicilia E
    J Inorg Biochem; 2021 Jun; 219():111447. PubMed ID: 33798829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monofunctional platinum(ii) anticancer complexes based on multidentate phenanthridine-containing ligand frameworks.
    Lozada IB; Huang B; Stilgenbauer M; Beach T; Qiu Z; Zheng Y; Herbert DE
    Dalton Trans; 2020 May; 49(20):6557-6560. PubMed ID: 32342084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.
    Riddell IA; Johnstone TC; Park GY; Lippard SJ
    Chemistry; 2016 May; 22(22):7574-81. PubMed ID: 27111128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationalization of the Superior Anticancer Activity of Phenanthriplatin: An In-Depth Computational Exploration.
    Dabbish E; Russo N; Sicilia E
    Chemistry; 2020 Jan; 26(1):259-268. PubMed ID: 31614021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA Intercalation Facilitates Efficient DNA-Targeted Covalent Binding of Phenanthriplatin.
    Almaqwashi AA; Zhou W; Naufer MN; Riddell IA; Yilmaz ÖH; Lippard SJ; Williams MC
    J Am Chem Soc; 2019 Jan; 141(4):1537-1545. PubMed ID: 30599508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage.
    Gregory MT; Park GY; Johnstone TC; Lee YS; Yang W; Lippard SJ
    Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9133-8. PubMed ID: 24927576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cancer characteristics and ototoxicity of platinum(II) amine complexes with only one leaving ligand.
    Monroe JD; Hruska HL; Ruggles HK; Williams KM; Smith ME
    PLoS One; 2018; 13(3):e0192505. PubMed ID: 29513752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Theory To Reinterpret the Kinetics of Monofunctional Platinum Anticancer Drugs: Stacking Matters.
    Veclani D; Melchior A; Tolazzi M; Cerón-Carrasco JP
    J Am Chem Soc; 2018 Oct; 140(43):14024-14027. PubMed ID: 30185041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis.
    Kellinger MW; Park GY; Chong J; Lippard SJ; Wang D
    J Am Chem Soc; 2013 Sep; 135(35):13054-61. PubMed ID: 23927577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
    Bierbach U; Sabat M; Farrell N
    Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Click-Capable Phenanthriplatin Derivatives as Tools to Study Pt(II)-Induced Nucleolar Stress.
    O'Dowd PD; Guerrero AS; Alley KR; Pigg HC; O'Neill F; Meiller J; Hobbs C; Rodrigues DA; Twamley B; O'Sullivan F; DeRose VJ; Griffith DM
    ACS Chem Biol; 2024 Apr; 19(4):875-885. PubMed ID: 38483263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of monofunctional platinum agents on bacterial growth: a retrospective study.
    Johnstone TC; Alexander SM; Lin W; Lippard SJ
    J Am Chem Soc; 2014 Jan; 136(1):116-8. PubMed ID: 24364388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenanthriplatin Acts As a Covalent Poison of Topoisomerase II Cleavage Complexes.
    Riddell IA; Agama K; Park GY; Pommier Y; Lippard SJ
    ACS Chem Biol; 2016 Nov; 11(11):2996-3001. PubMed ID: 27648475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two new monofunctional platinum(II) dithiocarbamate complexes:
    Imran M; Rehman ZU; Hogarth G; Tocher DA; Chaudhry GE; Butler IS; Bélanger-Gariepy F; Kondratyuk T
    Dalton Trans; 2020 Nov; 49(43):15385-15396. PubMed ID: 33140800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR and X-ray structural characterization of a cisplatin analogue able to slow down the Pt-N7 rotation of a coordinated guanine base by a billion-fold times: 2,2'-bipiperidine(dimethylmalonato)platinum(II) complex.
    Intini FP; Cini R; Tamasi G; Hursthouse MB; Natile G
    Inorg Chem; 2008 Jun; 47(11):4909-17. PubMed ID: 18447326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation relevant to the conformation of the 17-membered Pt(d(GpG)) macrocyclic ring formed by Pt anticancer drugs with DNA: Pt complexes with a Goldilocks carrier ligand.
    Maheshwari V; Marzilli PA; Marzilli LG
    Inorg Chem; 2011 Jul; 50(14):6626-36. PubMed ID: 21667929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of geometric isomerism on the anticancer activity of the monofunctional platinum complex trans-[Pt(NH
    Zhou W; Almeqdadi M; Xifaras ME; Riddell IA; Yilmaz ÖH; Lippard SJ
    Chem Commun (Camb); 2018 Mar; 54(22):2788-2791. PubMed ID: 29484327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G-G base-pairing in nucleobase adducts of the anticancer drug cis-[PtCl2(NH3)(2-picoline)] and its trans isomer.
    McGowan G; Parsons S; Sadler PJ
    Chemistry; 2005 Jul; 11(15):4396-404. PubMed ID: 15880542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.